Hypoxia-induced proliferation of human pulmonary microvascular endothelial cells depends on epidermal growth factor receptor tyrosine kinase activation
about
The Src family tyrosine kinases src and yes have differential effects on inflammation-induced apoptosis in human pulmonary microvascular endothelial cells.Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.Asymmetric dimethylarginine does not inhibit arginase activity and is pro-proliferative in pulmonary endothelial cells.Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling.Serum free cultured bone marrow mesenchymal stem cells as a platform to characterize the effects of specific moleculesArginase I gene single-nucleotide polymorphism is associated with decreased risk of pulmonary hypertension in bronchopulmonary dysplasia.Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancerProtein tyrosine nitration in cellular signal transduction pathways.Chronic hypoxia promotes pulmonary artery endothelial cell proliferation through H2O2-induced 5-lipoxygenase.Overexpression of cationic amino acid transporter-1 increases nitric oxide production in hypoxic human pulmonary microvascular endothelial cellsChronic hypoxia decreases arterial and venous compliance in isolated perfused rat lungs: an effect that is reversed by exogenous L-arginine.Role of arginase in vessel wall remodeling.Regulation of mitochondrial genome replication by hypoxia: The role of DNA oxidation in D-loop regionThioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation.Hypoxic upregulation of arginase II in human lung endothelial cellsThe pivotal role of reactive oxygen species generation in the hypoxia-induced stimulation of adipose-derived stem cells.Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction.Endothelial Nox1 oxidase assembly in human pulmonary arterial hypertension; driver of Gremlin1-mediated proliferation.Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.An arginase-1 SNP that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia enhances NO-mediated apoptosis in lymphocytes.Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension.Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells.Hypoxia-induced proliferation of tissue-resident endothelial progenitor cells in the lung.Hypoxic proliferation requires EGFR-mediated ERK activation in human pulmonary microvascular endothelial cells.Hypoxia induces arginase II expression and increases viable human pulmonary artery smooth muscle cell numbers via AMPKα1 signaling.Redox regulation of epidermal growth factor receptor signaling during the development of pulmonary hypertension.Pollutant particles induce arginase II in human bronchial epithelial cells.Hypoxic-induction of arginase II requires EGF-mediated EGFR activation in human pulmonary microvascular endothelial cells.
P2860
Q33891383-6C1AD1FE-E06F-492B-B45F-2494B1CD88A0Q33925368-97553967-EA5A-4B9A-BCA4-1B2F88C7E314Q33934764-C2845AEB-CACD-430A-A0E1-3A44D65CB3F3Q34062962-EF5B3F22-3303-4DAB-9E5E-14F121D7D1F3Q34117434-59C185C5-E783-4333-B6A5-207FBFF7A1F5Q34270453-AD9E350A-04F2-4194-A725-A756C43E59A3Q34592559-B761D154-FE04-43F8-8553-8BDF45374E53Q34872656-7C3AD8ED-F885-413D-B15C-E79A9D50AE3BQ35183085-AC234E06-3C5E-45BE-8573-7374DF7ABE56Q35577603-0B50CC11-1AF3-4D62-A167-744F6ACD5189Q36528050-59DD3EE1-1E0C-4375-8FA8-9E54DEF450AAQ36837617-26B6D812-F1E9-4F16-B6D6-DE02B6AE807FQ37017150-D7C21050-22CC-4237-A0FF-B74527D0F607Q37147096-E9999B7C-A7B2-4144-9844-1EE87FF30802Q37174204-F5AF88B6-E5F1-4F11-A509-96F17180160BQ38583113-6C3A1AD0-7A8A-49DA-9518-4590880944ECQ38711129-FB752C2E-420A-45A1-9FF7-70A599F8A1CEQ38776018-7A48C48E-EEB7-45BC-A823-2D89A33F8301Q39109514-AF14E29E-173C-4263-9B77-2BA4799DA13BQ39147384-4488F0D2-E07F-4FC4-87D7-44B7EF2A885FQ41572947-2AF9BBE4-949A-42D1-BA39-380935CC91FDQ41860957-A933EAB2-E518-425A-82AA-61866D351367Q46799116-3F2A3B2E-ED98-4BDE-8601-F77EC549E913Q47976677-AAA8ECA8-831E-4DBD-84E1-82CEADA24679Q51132736-362E033C-E891-468B-94E7-8B2D4EAF499BQ52668831-4492746E-FAD1-4139-9E6B-DFC4CBC05AE7Q54503317-60631860-8756-4B8B-81F4-C428069765F0Q55545711-BC4EE198-F8E1-470F-9C6C-274F94089CF8
P2860
Hypoxia-induced proliferation of human pulmonary microvascular endothelial cells depends on epidermal growth factor receptor tyrosine kinase activation
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hypoxia-induced proliferation ...... tor tyrosine kinase activation
@ast
Hypoxia-induced proliferation ...... tor tyrosine kinase activation
@en
type
label
Hypoxia-induced proliferation ...... tor tyrosine kinase activation
@ast
Hypoxia-induced proliferation ...... tor tyrosine kinase activation
@en
prefLabel
Hypoxia-induced proliferation ...... tor tyrosine kinase activation
@ast
Hypoxia-induced proliferation ...... tor tyrosine kinase activation
@en
P2093
P2860
P1476
Hypoxia-induced proliferation ...... tor tyrosine kinase activation
@en
P2093
Bernadette Chen
Hongmei Cui
Inimary T Toby
Leif D Nelin
Louis G Chicoine
P2860
P304
P356
10.1152/AJPLUNG.00122.2009
P577
2010-02-05T00:00:00Z